Literature DB >> 20671874

Evaluation of cardiovascular risk in blood donors: results of the CARDIORISK study in the Parma Transfusion Service.

Paolo Dell'anna1, Daniela Adorni, Gino Bernuzzi, Stefano Cantarelli, Alberto Cepparulo, Tiziano Cocchi, Loretana Dell'anna, Alessandro Formentini, Maria Sassi, Fiorella Scognamiglio, Maurizio Vescovi, Massimo Franchini.   

Abstract

BACKGROUND: Cardiovascular disease, which is one of the main causes of mortality in industrialised countries, is ever increasingly the focus of prevention. In this study, called "Cardiorisk", we evaluated cardiovascular risk in the population of blood donors at the Service of Immunohaematology and Transfusion Medicine in Parma. PATIENTS AND METHODS: Between January 2007 and December 2008, 6,172 consecutive blood donors (aged 35-65 years) were enrolled in this project which entailed calculating each subject's cardiovascular risk score, based on an evaluation of both unalterable risk factors (age and gender) and modifiable risk factors (total cholesterol, HDL, LDL, triglycerides, glycaemia, smoking, hypertension) as well as anti-hypertensive and/or cholesterol-lowering therapy.
RESULTS: Of the 6,172 donors enrolled in the study, 5,039 (81.7%) had a low cardiovascular risk (score from 0-10), 774 (12.5%) had a moderate cardiovascular risk (score from 11-19) and 359 (5.8%) donors had a high cardiovascular risk (score from 20-28).
CONCLUSIONS: In our opinion, the calculation of cardiovascular risk is an important instrument for preventive medicine in blood donors.

Entities:  

Keywords:  blood donors; cardiovascular risk factors; cardiovascular risk score

Mesh:

Year:  2010        PMID: 20671874      PMCID: PMC2906184          DOI: 10.2450/2009.0097-09

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  15 in total

1.  Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study.

Authors:  A Menotti; P E Puddu; M Lanti
Journal:  Eur Heart J       Date:  2000-03       Impact factor: 29.983

2.  Evolution of NCEP guidelines: ATP1-ATPIII risk estimation for coronary heart disease in 2002. National Cholesterol Education Program.

Authors:  C Richard Conti
Journal:  Clin Cardiol       Date:  2002-03       Impact factor: 2.882

3.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

4.  Reducing the risk of stroke.

Authors:  Kamakshi Lakshminarayan; David C Anderson
Journal:  JAMA       Date:  2003-04-16       Impact factor: 56.272

Review 5.  The value of lowering cholesterol after myocardial infarction.

Authors:  J E Rossouw; B Lewis; B M Rifkind
Journal:  N Engl J Med       Date:  1990-10-18       Impact factor: 91.245

6.  Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease.

Authors:  J Pekkanen; S Linn; G Heiss; C M Suchindran; A Leon; B M Rifkind; H A Tyroler
Journal:  N Engl J Med       Date:  1990-06-14       Impact factor: 91.245

7.  Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association.

Authors:  S M Grundy; G J Balady; M H Criqui; G Fletcher; P Greenland; L F Hiratzka; N Houston-Miller; P Kris-Etherton; H M Krumholz; J LaRosa; I S Ockene; T A Pearson; J Reed; R Washington; S C Smith
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

8.  Lifetime risk of developing coronary heart disease.

Authors:  D M Lloyd-Jones; M G Larson; A Beiser; D Levy
Journal:  Lancet       Date:  1999-01-09       Impact factor: 79.321

9.  Serum cholesterol as a prognostic factor after myocardial infarction: the Framingham Study.

Authors:  N D Wong; P W Wilson; W B Kannel
Journal:  Ann Intern Med       Date:  1991-11-01       Impact factor: 25.391

10.  Cross-sectional epidemiological study to evaluate the cardiovascular profile of a cohort of blood donors.

Authors:  Marcella Longo; Carla Lucci; Maurizio Marconi; Giovanna Cremonesi
Journal:  Blood Transfus       Date:  2007-07       Impact factor: 3.443

View more
  2 in total

1.  The relationship between ABO blood group and cardiovascular disease: results from the Cardiorisk program.

Authors:  Enrico Capuzzo; Carlo Bonfanti; Francesco Frattini; Paolo Montorsi; Rosalia Turdo; Maria Grazia Previdi; Elisa Turrini; Massimo Franchini
Journal:  Ann Transl Med       Date:  2016-05

2.  Homocysteine and education but not lipoprotein (a) predict estimated 10-year risk of cardiovascular disease in blood donors: a community based cross-sectional study.

Authors:  Francesco Vadini; Francesca Santilli; Giuseppe Casalini; Mario dell'Isola; Ornella Iuliani; Damiano D'Ardes; Luisa Lattanzio; Marta Di Nicola; Giancarlo Di Iorio; Patrizia Accorsi
Journal:  BMC Cardiovasc Disord       Date:  2019-07-26       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.